{
    "Trade/Device Name(s)": [
        "SmartAdjust\u2122 Technology",
        "SmartAdjust\u2122 technology"
    ],
    "Submitter Information": "Insulet Corporation",
    "510(k) Number": "K241777",
    "Predicate Device Reference 510(k) Number(s)": [
        "K232741"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QJI"
    ],
    "Summary Letter Date": "June 20, 2024",
    "Summary Letter Received Date": "June 20, 2024",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1356"
    ],
    "Regulation Name(s)": [
        "Interoperable Automated Glycemic Controller"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine",
        "POCT"
    ],
    "Analyte(s)": [
        "Glucose",
        "Insulin"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Omnipod 5 ACE Pump",
        "Omnipod 5 Pod",
        "Omnipod 5 Controller",
        "Compatible iCGM"
    ],
    "Method(s)/Technology(ies)": [
        "Algorithmic software device",
        "Bluetooth Low Energy wireless technology"
    ],
    "Methodologies": [
        "Automated insulin delivery",
        "Hybrid closed loop system"
    ],
    "Submission Type(s)": [
        "Software",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for SmartAdjust\u2122 technology software enabling automated insulin delivery for diabetes management via integrated CGM and ACE pump.",
    "Indications for Use Summary": "Intended for automatic adjustment of insulin delivery in persons with type 1 diabetes (2+ years) and type 2 diabetes (18+ years) using compatible CGM and ACE pumps; single patient, prescription use.",
    "fda_folder": "Clinical Chemistry"
}